⌘K

Home/Filings/4/0001104659-20-127310

4//SEC Filing

Corin Denis 4

Accession 0001104659-20-127310

CIK 0001596062other

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 3:48 PM ET

Size

9.7 KB

Accession

0001104659-20-127310

Insider Transaction Report

Form 4

Period: 2020-08-29

Q BioMed Inc.QBIO

DirectorChief Executive Officer10% Owner

Transactions

Award
Incentive Stock Options
2020-08-29+150,000→ 1,850,000 total
Exercise: $1.50From: 2021-03-01Exp: 2025-08-29→ Common Stock (150,000 underlying)
Award
Incentive Stock Options
2020-08-29+150,000→ 2,000,000 total
Exercise: $1.50From: 2021-03-01Exp: 2025-08-29→ Common Stock (150,000 underlying)
Award
Incentive Stock Options
2020-10-27+500,000→ 2,500,000 total
Exercise: $1.03From: 2021-04-27Exp: 2025-10-27→ Common Stock (500,000 underlying)

Footnotes (2)

[F1]Issued for officer services.
[F2]Issued for director services.

Documents

1 file

4
tm2036483d2_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Q BioMed Inc.

CIK 0001596062

Entity typeother

Related Parties

1

filerCIK 0001405626

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 3:48 PM ET
Size: 9.7 KB

View on SEC.gov